Literature DB >> 8391477

Molecular cloning of two receptors from rat brain with high affinity for salmon calcitonin.

K Albrandt1, E Mull, E M Brady, J Herich, C X Moore, K Beaumont.   

Abstract

Two receptors with high affinity for salmon calcitonin were cloned from the nucleus accumbens region of rat brain. The deduced 479 amino acid sequence of cDNA clone L2175-D20 (designated C1a receptor) is 78% and 66% identical with those reported for human and porcine calcitonin receptors, respectively. Clone U3237-A2 codes for a receptor (designated C1b) that is identical to C1a except for a 37 amino acid insert in the second extracellular domain. COS-7 cells transfected with either transcript bound [125I]salmon calcitonin with high affinity (Kd = 8 pM for C1a; Kd = 48 pM for C1b) and responded to salmon calcitonin with increases in cAMP. Tissue distribution studies revealed C1a transcript in rat brain, skeletal muscle, kidney and lung, whereas C1b was predominantly found in brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391477     DOI: 10.1016/0014-5793(93)81078-e

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  The delta e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling.

Authors:  Thomas Seck; Maria Pellegrini; Ana Maria Florea; Veronique Grignoux; Roland Baron; Dale F Mierke; William C Horne
Journal:  Mol Endocrinol       Date:  2005-04-28

Review 2.  Consequences of splice variation on Secretin family G protein-coupled receptor function.

Authors:  Sebastian G B Furness; Denise Wootten; Arthur Christopoulos; Patrick M Sexton
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Amylin activates distributed CNS nuclei to control energy balance.

Authors:  Elizabeth G Mietlicki-Baase; Matthew R Hayes
Journal:  Physiol Behav       Date:  2014-01-28

4.  Calcitonin inhibits prolactin promoter activity in rat pituitary GGH3 cells: evidence for involvement of p42/44 mitogen-activated protein kinase in calcitonin action.

Authors:  Yuan Ren; Ya-Ping Sun; Girish V Shah
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

5.  Calcitonin inhibits prolactin gene transcription in rat pituitary cells.

Authors:  Q Xue-Zhang; S M Stanley; G V Shah
Journal:  Endocrine       Date:  1995-06       Impact factor: 3.633

6.  CGRP and the Calcitonin Receptor are Co-Expressed in Mouse, Rat and Human Trigeminal Ganglia Neurons.

Authors:  Tayla A Rees; Andrew F Russo; Simon J O'Carroll; Debbie L Hay; Christopher S Walker
Journal:  Front Physiol       Date:  2022-05-10       Impact factor: 4.755

7.  Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction.

Authors:  A H Gorn; S M Rudolph; M R Flannery; C C Morton; S Weremowicz; T Z Wang; S M Krane; S R Goldring
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

8.  A synthetic peptide derived from mouse pituitary calcitonin cDNA sequence exhibits potent inhibition of prolactin secretion and prolactin mRNA abundance in primary mouse pituitary cells.

Authors:  Trupti Kulkarni-Paranjape; Girish V Shah
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

9.  Endogenous VMH amylin signaling is required for full leptin signaling and protection from diet-induced obesity.

Authors:  Ambrose A Dunn-Meynell; Christelle Le Foll; Miranda D Johnson; Thomas A Lutz; Matthew R Hayes; Barry E Levin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-12-16       Impact factor: 3.619

10.  Identification of the calcitonin receptor in osteoarthritic chondrocytes.

Authors:  Toni Segovia-Silvestre; Caroline Bonnefond; Bodil C Sondergaard; Tjorbjoern Christensen; Morten A Karsdal; Anne C Bay-Jensen
Journal:  BMC Res Notes       Date:  2011-10-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.